In the present study, we have demonstrated that ACh is the predominant fast excitatory transmitter used by identified motor neurons innervating feeding muscles in Aplysia. A detailed study of ACh metabolism was then carried out in a well-characterized neuromuscular preparation, intrinsic muscle 5 (15). This neuromuscular system has a high-affinity uptake system for choline. The rate of uptake of choline was increased by motor neuron stimulation, and this increased uptake appears to be selectively targeted to motor neuron terminals.
These properties appear similar to those observed in vertebrate neuromuscular preparations. However, we have made two observations that are surprising in light of our knowledge concerning the vertebrate neuromuscular junction where released ACh is rapidly hydrolyzed by acetylcholinesterase (AChE) to choline, which is then taken up by a high-affinity uptake system. This Aplysia neuromuscular system has limited endogenous AChE activity and contains a separate high-affinity uptake system for ACh itself that actually has a higher velocity than that for choline uptake. It is possible that the uptake system for ACh is involved in terminating the action of released transmitter in a manner similar to that previously described for noncholinergic transmitters. Using this preparation, we have demonstrated release of labeled ACh in response to intracellular stimulation of identified motor neurons. The release per spike appears to be highly plastic, increasing markedly with stimulation frequency.
This preparation is amenable to study the regulation of release of peptide and conventional transmitters from the terminals of individual neurons. [Key words: cholinergic synapse, AChE, ChAT, ACh uptake, cofransmitters, neuromuscular] Acetylcholine (ACh) is the fast excitatory transmitter used at some neuromuscular synapses in mollusks, The release of peptide cotransmitters from select cholinergic neuromuscular synapses have been studied extensively in Aplysia, but little atten- Received Dec. 30, 1993; revised Apr. 13, 1994; accepted Apr. 28, 1994 . We thank L. E. Fox, G. A. Phares, and M. D. Whim for critical reading of the manuscript.
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Correspondence should be addressed to Philip E. Lloyd tion has been given to ACh synthesis, release, and inactivation at the same synapses. We set out to investigate these phenomena in a preparation consisting of neuromuscular synapses between two identified cholinergic motor neurons (B I5 and B 16; Cohen et al., 1978) and the muscle fibers of intrinsic muscle 5 (IS; Howells, 1942 ; also called the ARC muscle). B I5 and B16 are members of the ventral cluster of motor neurons (MNs) that innervate buccal muscles involved in generating biting and swallowing movements. In addition to ACh, both MNs also contain several modulatory neuropeptide transmitters. B15 contains the small cardioactive peptides (SCPs) and the buccalins, while B 16 contains the buccalins and the myomodulins (Cropper et al., 1987a (Cropper et al., ,b, 1988 (Cropper et al., , 1990b Church and Lloyd, 1991) . At the ultrastructural level, SCP-like immunoreactivity is located in densecore vesicles in varicosities in this muscle (Cropper et al., 1987a) . These same varicosities also contain smaller electron-luscent vesicles similar to cholinergic vesicles described in other animals. Recently, the release of the SCPs from the terminals of B 15 in 15 muscle was demonstrated Lloyd, 1989, 1990; Cropper et al., 1990a) . This release is sharply dependent on the stimulation parameters with significant release of the SCPs only occurring with stimulation at a relatively high frequency for bursts of long duration. Since B 15 can produce cholinergically mediated contractions with stimulation parameters that do not cause measurable release of the SCPs, it appears that B 15 can function in two states: as a predominantly cholinergic neuron, or as a combined cholinergic/peptidergic neuron . The determination of the factors that regulate the metabolism of multiple transmitters released from individual neurons is vital to our understanding of neuronal function (Bartfai et al., 1988; Kupfermann, I99 1) .
In the present study, we have set out to determine how commonly ACh is used as the fast excitatory transmitter in ventral cluster MNs. We then concentrated our study of ACh metabolism on the I5 neuromuscular preparation. We have made two observations that are surprising in light of our knowledge concerning the vertebrate neuromuscular junction where released ACh is rapidly hydrolyzed by acetylcholinesterase (AChE) to choline, which is then taken up. First, these Aplysia neuromuscular synapses have very limited endogenous AChE activity. Second, this preparation contains a separate high-affinity uptake system for ACh itself that actually has a higher velocity than the high-affinity uptake system for choline. It is possible that the uptake system for ACh is involved in terminating the action of released transmitter in a manner similar to that described for biogenic amines and amino acid transmitters at other synapses (Amara and Kuhar, 1993 Lloyd, 1989, 1990 ). Intracellular iniection of 'H-choline and svnthesis of labeled ACh. Individual MNs were identified as described. previously (Church and Lloyd, 199 1; Church et al., 1993 ) using a series of criteria that included size and position within the buccal ganglion, synaptic connections from identified intemeurons, axonal projections, and the identity of the muscles they innervate. Electrodes were tip filled with a solution of 1 M KCl, 0.5% fast green, and 'H-choline (-70 Ci/mmol; Amersham) concentrated to 200 mCi/ml. These electrodes were acceptable for voltage recording and were used to pressure inject the solution. Since the final concentration of choline in the electrode was low (3 PM), the injections were small (< 1% of cell volume), and normal concentrations of choline in Aplysia neurons are over 100 PM (McCaman et al., 1973) , the injections would have little effect on intracellular choline levels. Filling was monitored visually by the change in cell color. After injection, the ganglion was incubated for 1 hr in normal (n) ASW containing 10 PM unlabeled choline to inhibit uptake of any leaked labeled choline. Neuronal cell bodies were dissected manually using freeze substitution (Ono and McCaman, 1980) and extracted into a tube containing 50 ~1 of 85% ethanol, 15% 1 M acetic acid, and 300 nmol each of unlabeled choline and ACh. This tube was kept on dry ice, and then stored at -20°C. Samples were dried and analyzed by HPLC to determine the fate of the injected labeled choline (see below).
UptakeopH-cholineand'H-ACh into I5 neuromuscularpreparations. Animals were immobilized with an injection of isotonic MgCl,. All dissections were carried out in high-Mg'+ (110 mM), low-Ca'+ (0.5 mM) ASW. Paired I.5 muscles were cut from the remainder of the buccal mass and cut in half longitudinally to produce four muscle sections. These were washed extensively with nASW for at least 3 hr to wash as much blood (which contains both choline and cholinesterate activity) as possible from the muscle. Constant agitation was used to ensure mixing during all washes and incubations described here and below. Muscle sections were incubated in lo-50 nM 'H-choline or 3H-ACh. In some cases, additional unlabeled choline or ACh was added to yield the correct total concentration. In most cases, bath volumes were -lOOOfold larger than muscle volumes to prevent significant depletion and to ensure that there was limited hydrolysis of ACh (see below). At the end of the incubation periods (3-100 min), muscle segments were washed for 15 min each in two consecutive baths containing high-Mg2+/lowCa*+ ASW with no added choline or ACh. One limitation of these experiments is that in resting muscles at very low bath concentrations of choline, it is likely that the efflux of,endogenous choline from the muscles would increase the local concentration of choline above that in the bath. This may also be a problem with ACh when the neuromuscular preparation is stimulated. Because of these limitations and the complexity of uptake systems in this preparation, we have only described the separate uptake systems in a qualitative fashion.
Dissection of the I5 neuromuscular system. These were carried out in a fashion similar to those already described (Whim and Lloyd, 1989) . In brief, the buccal mass/buccal ganglia complex was removed from the animal and cut in half. In experiments involving intracellular stimulation of B15 or B16, the hemiganglion containing the cell bodies of these MNs was left attached to the muscle via buccal nerve 3 (N3), which contains their motor axons. A third MN, termed Bl 1, is also cholinergic and has its axon in N3 but it produces very small EJPs in the I5 muscle fibers and primarily innervates another muscle (Jordan et al., 1993) . All other nerves and connectives were severed. In experiments using extracellular suction electrodes, N3 was cut near its connection to the hemiganglion. In all experiments, the muscle that provides a base for I5 was trimmed as much as possible without damaging N3 (see Fig. 1 ; Weiss et al., 1978) . After dissection, all preparations were washed extensively with nASW for at least 3 hr to wash as much blood as possible from the muscles.
LoadinP IS neuromuscular oreuarations with 'H-choline. N3 stimulation in&eased 'H-choline uptake and synthesis of labeled ACh (see Results). In most experiments, stimulation was used to "load" the preparation with labeled ACh probably primarily in the presynaptic terminals (see Results). In experiments with N3 cut, a suction electrode was used to stimulate N3 (4 set 25 Hz bursts with 6 set intervals for Figure 1 . HPLC profiles of ACh peak incubated in buffer (pH 7.8) for 60 min (Control) or with AChE in the same buffer (AChE). The ACh peak was obtained by HPLC of a buccal ganglion incubated in )Hcholine for 30 min, which is sufficient period for the ganglion to take up the choline and synthesize labeled ACh. The ganglion was then extracted and run with the same gradient shown here to obtain the labeled ACh peak used in these incubations, Note that AChE hydrolyzed all of the label in the ACh peak to a substance with the same retention time as choline (Ch). Dashed lines indicate retention times of unlabeled choline and ACh added to the samples and monitored by absorbance at 206 nm. Essentially the same results were obtained for the ACh peak purified from I5 muscle, or with the ACh peaks from either buccal ganglion or muscle incubated for 60 min under basic conditions (pH 10). 30 min) during incubation in 'H-choline (-70 Ci/mmol; Amersham). When N3 remained connected to the buccal ganglion, the nerve was stimulated by placing it through a petroleum jelly gap (Lloyd, 1988) and passing brief (1.5 msec) current pulses across the gap with silver chloride electrodes. This procedure was used because long term en passant stimulation with a suction electrode occasionally damages axons.
Collection of labeled substances released from loaded I5 neuromuscular preparations. The 15 muscle was positioned with a retractable hook into a collection apparatus with a bath volume of 30 ~1 and was perfused via a peristaltic pump at a flow rate of 333 &min (one bath volume/5 set). The base muscle provided an effective seal for the collection apparatus . Outflow was collected into vials, scintillation fluid added, and the samples counted without further extraction. Collection periods of 3 min (volume, 1 ml) were used throuahout. Counting efficiency including quenching by the ASW was -56%. In some experiments, the scintillation vials were spiked with 100 ~1 of 110 mM heptafluorobutyric acid (HFBA), 10 mM triethylamine (TEA) containing 300 nmol each of unlabeled choline and ACh. Portions of these collected samples were analyzed by HPLC (see below). The collection apparatus was also used as an extracellular electrode to ensure that EJPs followed intracellular somatic spikes one for one. Silver chloride electrodes were placed inside and just outside the apparatus, which was pressed firmly onto the base muscle. Electrodes were attached to a Grass P15 A.C. amplifier. The inflow reservoir was shielded to reduce noise.
Determination of cholinesterase activity. I5 muscles were dissected away from the base muscle and cut longitudinally into two segments. Neuron Figure 2 . A, HPLC profiles of extracts from single identified neuronal somata injected with 3H-choline. Neurons were dissected and extracted -1 hr after injection. B3 profile is typical of neurons that synthesized very low levels of labeled ACh ( < 1.5%). BI 5 profile is typical of neurons that synthesized high levels of labeled ACh (> 30%). Additional pharmacological data indicate that B 15 is cholinergic while B3 is not. Dashed lines indicate retention times of unlabeled Ch and ACh added to cell extracts and monitored by absorbance at 206 nm. Total recovered counts reflects the fact that B3 is a larger neuron than B 15. The identities of the labeled material with retention times between 3 and 4 min has not been determined (see text). B, Summary of the results from 'H-Ch injections into identified neuronal somata in the buccal ganglion, Neurons 1 and 2 regulate contractile activity of the gut while all the other neurons make excitatory or inhibitory neuromuscular synapses on buccal muscle. Identifying characteristics of neurons up to 45 have been described previously (Church and Lloyd, 199 1) . MN B46 is located adjacent to B2 and provides excitatory innervation to muscle I1 via nerve 2. B47 is an inhibitory MN described elsewhere . %ACh, percentage of total recovered label that coeluted with unlabeled ACh. Values are mean * SD (n t 4).
These were then washed for -3 hr in eight changes of nASW to wash as much blood as possible from the muscle segments. Cholinesterase activities were measured by incubating muscle segments (segments weighing l-4 mg were incubated at a ratio of 1 mgwet weigh?10 ~1 nASW) or freshlv collected blood (1 ul blood/l0 vl nASW) with 10 ILM 'H A&. At intervals, the bath and muscle segment were extracted~and analyzed by HPLC (see below). In most cases, parallel experiments were carried out with 100 PM eserine sulphate (Sigma) added to the nASW.
Intracellular stimulation of B15 or BI6. The ganglion and base muscles were continuously superfused with high-Mg2+/low-Ca2+ ASW to suppress synaptic transmission. Motor neurons were impaled with two electrodes (R -10 MQ), one to pass current and the other to monitor' voltage. Intracellular spikes were individually generated by 10 msec depolarizing current pulses. B16 was often spontaneously active so in experiments involving B 15, B 16 was impaled and mechanically lesioned before the start of the experiment. Lesions of the cell body produced a brief volley of high-frequency EJPs in I5 muscle and then no further EJPs that were not evoked by B15 stimulation were observed. In experiments involving B16, the cell was hyperpolarized tonically between stimulation periods. B15 was never spontaneously active under these experimental conditions. Analysis of labeled substances by HPLC. Labeled ACh could be separated completely from labeled choline and other labeled substances by reverse phase HPLC on an Isco 5 x 250 mm C8 (5 rm) column with a gradient from 8% to 20% CH,CN in 7 min. and then held at 20% for 2 min before reequilibration. Both H,O and CH,CN solutions contained 11 rnr+r HFBA and 1 mM TEA. All HPLC iniections contained lOO-300 nmol each of unlabeled choline and ACh. The elution of these compounds was monitored at 206 nm. Fractions (0.5 min) were collected and counted after the addition of scintillation fluid. Labeled ACh peaks were prepared by incubating either buccal ganglia or 15 muscle (with stimulation of N3) in 50 nM 3H-choline. Extracts from the ganglia or muscle were run on HPLC to purify the ACh peaks. The nature of the label in these peaks was analyzed using three procedures: (1) incubation with electric eel AChE (Sigma V-S; 10 U/ml, pH 7.8, 60 min, 22°C) followed by HPLC (Fig. 1) ; (2) incubation under basic conditions (5 mM NaOH, pH 10, 60 min, 22°C) followed by HPLC; (3) a second mode of HPLC using 20 mM TEA acetate, 0.1 mM Na octyl sulfate (pH 5) as the mobile phase with the same column. Incubation with AChE or NaOH resulted in complete hydrolysis (>99%) of the labeled ACh peak from either ganglia or muscle to a labeled substance that has the same retention time as choline (e.g., Fig. 1 ). In addition, the label in the ACh peaks continued to coelute with 'H-ACh run in parallel on the second mode of HPLC. Using these three criteria, we conclude that essentially all of the label in the ACh peak is labeled ACh.
Results

Identijied motor neurons in buccal ganglia are predominantly cholinergic
The first question we wished to answer is how commonly ACh is used as the fast excitatory transmitter at neuromuscular synapses in buccal muscle. It has been shown that a powerful criterion to determine if an Aplysia neuron is cholinergic is to measure the synthesis of ACh from injected labeled choline (Eisenstadt et al., 1973; Cohen et al., 1978) . Apparently, cholinergic somata in Aplysia contain significant choline acetyltransferase (ChAT) activity while noncholinergic neurons contain very little ChAT activity (Giller and Schwartz, 1971a) . Individual MNs were identified using a battery of criteria (Church and Lloyd, 199 1; Church et al., 1993) and a solution containing 3H-choline was pressure injected into each somata. After incubation, individual somata were dissected, processed, and analyzed by HPLC to separate labeled choline, ACh, and other substances. Figure 2 shows examples of the labeling patterns of neurons B15 and B3. B15 is cholinergic by the criteria that it contains significant ChAT activity and that its EJPs are blocked by hexamethonium and B3 is noncholinergic by the criteria that it contains essentially no ChAT activity ( Fig. 2 ) and its EJPs are not blocked by hexamethonium (Lotshaw and Lloyd, 1990) . Using our extraction procedures and HPLC, we observed a major peak of label with short retention time that apparently was not observed in previous studies using paper electrophoresis to separate labeled substances from Aplysia neurons. This substance(s) appears to be a major product in both cholinergic and noncholinergic neuronal extracts. Labeled substance(s) with similar retention times were also observed in muscles which took up 3H-choline from the bath (e.g., Figs. 9, 12) or crude muscle extracts incubated with 'H-choline. However, boiling of the extracts before incubation with 3H-choline prevented the appearance of this substance(s), suggesting that its production was enzymatic. Several common choline metabolites do have similar retention times with this peak. These include betaine and cytidine diphosphocholine, but not phosphorylcholine, which has a retention time between those of choline and ACh. Since this substance(s) does not appear to be involved in cholinergic transmitter function (see below) and was only slightly retained by the column, its identity has not been further pursued. Figure 2B summarizes the results from 3H-choline injections into identified MNs. ChAT activity of individual neurons fell into two categories. In one category, labeled ACh represents 30% or more of the recovered label (mean of all cells in this category, 37.8 + 6.9%, ?SEM). Note that the ChAT activities of previously identified cholinergic neurons fall into this group (B4, B5, B15, B16, B47; Gardner and Kandel, 1977; Church et al., 1993) . In the other category, labeled ACh was less than 1.5% of recovered label (mean of all cells in this category, 0.8 f 0.3%). Of these neurons, additional pharmacological evidence confirmed that B3 and B38 are not cholinergic (Lotshaw and Lloyd, 1990; Church et al., 1993) . These results suggest that 17 of 2 1 identified MNs are cholinergic. One of these cholinergic neurons is inhibitory (B47) and two are inhibitory/excitatory (B4 and BS). The four noncholinergic neurons are excitatory, and there is evidence that their conventional transmitter may be an excitatory amino acid, most likely glutamate (Fox and Lloyd, 1993) . Thus, the most prevalent fast excitatory transmitter used by buccal MNs is ACh.
Separate uptake systems for ACh and choline are present in I5 neuromuscular preparations We concentrated our investigations of choline and ACh metabolism on the 15 neuromuscular system since this preparation has been extensively studied. It is important to emphasize that in all cases the preparations were washed extensively with nASW for several hours to wash away as much blood as possible. This step was necessary because the blood contains significant amounts of choline (-10 I.LM; Schwartz et al., 1975) and AChE activity (Giller and Schwartz, 197 lb; Bevelaqua et al., 1975 ; also see below). 15 muscle preparations consist primarily of muscle fibers with a small proportion of the muscle volume being the axons and terminals of B15 and B16 .
To study the metabolism of choline and ACh, we first investigated the ability of 15 neuromuscular preparations to hydrolyze labeled ACh. In contrast to vertebrate neuromuscular junctions (Potter, 1970) , 15 neuromuscular preparations contain little cholinesterase activity (see below). In the absence of blood, there is measurable but limited hydrolysis of ACh. Because measurements of AChE activity are complicated by the uptake of unhydrolyzed ACh, they will be described after the uptake experiments.
When incubated with low concentrations (50 nM) of labeled choline or ACh, 15 muscle segments actively concentrated both substances linearly with respect to time (Fig. 3) . The velocity of ACh uptake was approximately fourfold greater than choline uptake. These are active processes. For example, after incubation for 100 min, labeled ACh was concentrated 45-fold over bath levels and choline was concentrated IO-fold. Uptake at early time points indicates little lag at the beginning of the incubations suggesting that the labeled substances diffused rap- muscles. Muscle segments were incubated with 50 nM ACh or Ch for the indicated times. ACh is taken up at a rate approximately fourfold higher than Ch and both are taken up at a linear rate for at least 100 min. Muscle : bath ratio was calculated as (cpm/mg wet weight muscle) + (cpm/rl bath). This leads to a moderate underestimate of uptake as some of the muscle is extracellular space. Values are mean ? SD (n = 3).
idly to the uptake sites. In these experiments and those described below, we added no AChE inhibitors, but bath volumes were about lOOO-fold greater than muscle volumes so that only a small portion of ACh was hydrolyzed (AChE activity was determined with bath volumes only 1 O-fold greater than muscle). This large volume ratio also prevented the uptake from significantly depleting bath levels of ACh or choline. The finding that the uptake of ACh had a considerably higher velocity than that of choline suggests that the uptake of choline hydrolyzed from ACh must be a very small component of the observed ACh uptake. In addition, HPLC of muscle segments incubated in labeled ACh indicated that most of the total label remained as ACh (67 + 5%, &SD, IZ = 12).
The ratio of ACh uptake to choline uptake was dependent on concentration (Fig. 4) . ACh was taken up at a rate approximately fourfold higher than choline up to concentrations of -10 PM. At higher concentrations, this ratio declined and ACh and choline were taken up at the same rate at 330 /IM and above. A possible explanation for these results is that there are two uptake systems, one that functions at high concentrations, has a high capacity, and does not distinguish between choline and ACh, and a second process that has a higher affinity than the first process and is selective for ACh. The concentration dependence of the uptake of labeled choline and ACh were also determined (Fig. 5A) . The curves do not saturate and indeed the curve for choline is nearly linear as was also observed for choline uptake into the Apfysia CNS . If the explanation given above is correct, then subtracting uptake of choline from the uptake of ACh should produce a saturating curve that would represent the high-affinity uptake selective for ACh. Such a curve is indeed generated and indicates that the high-affinity uptake of ACh appears to have a K,,, between 5 and 10 PM (Fig. 5B) .
Additional support for the explanation given above comes from experiments using choline or ACh in competition experiments. High concentrations (1 mM) of choline or ACh equally reduced uptake of labeled choline, but ACh was much more effective than choline at reducing ACh uptake (Fig. 6) . One explanation for these results is that unlabeled ACh competes effectively with the high affinity uptake selective for ACh as well as with the lower-affinity/high-capacity system that takes up both ACh and choline. By contrast, unlabeled choline only competes effectively with the lower affinity system that takes up both ACh and choline. Hemicholinium-3 (HC-3) has been used extensively as an inhibitor of choline uptake at vertebrate cholinergic synapses (e.g., Potter, 1970) . However, in 15 neuromuscular preparations, HC-3 (1 mM) was less effective than choline itself at blocking choline uptake, and less effective than ACh itself at blocking ACh uptake. Taken together with results from central ganglia , it appears that HC-3 is not an effective inhibitor of choline or ACh uptake in Aplysia.
Many high-affinity uptake systems are dependent on external Na+ concentrations (Amara and Kuhar, 1993) . In the 15 neuromuscular system, choline and ACh uptake showed markedly different dependencies on external Na+ (Fig. 7) . To ensure that uptake is through a high-affinity system, low concentrations (10 nM) of either choline or ACh were used. Replacing all but 5 mM Na+ (normal Na+ concentration in ASW is 460 mM) with N-methyl glucamine inhibited ACh uptake 1 O-fold but reduced choline uptake less than twofold. Using Tris to replace Nat produced a larger inhibition of both choline and ACh uptake, suggesting that Tris has some other effects in addition to replacing Na+. Nevertheless, with either N-methyl glucamine or Tris replacing Na+, ACh uptake was inhibited approximately fivefold more effectively than choline uptake. These results provide additional evidence for the existence of a separate uptake system for ACh.
Choline uptake and metabolism have been extensively studied in central ganglia of Aplysia , but this . A, Concentration dependence of ACh and Ch uptake into 15 muscle segments. Unlabeled ACh or Ch were added to 10 nM 3H-ACh or SH-Ch to produce the indicated concentrations. Incubation periods were 30 min. Uptake of ACh and Ch was linear for at least 50 min at low concentrations (e.g., Fig. 3) and at the highest concentration tested (100 PM; data not shown). Muscle segments were paired so that one segment from an animal was incubated with a particular concentration of ACh while the a second segment from the same animal was incubated with the same concentration of Ch. Values are mean ? SD (n = 3). B, Subtracting uptake of ACh from uptake of Ch for each pair of muscle segments incubated with the same concentrations of ACh and Ch yields a saturating curve. Values are mean + SD (n = 3). study did not address the possibility of ACh uptake. Accordingly, we wished to determine if a high-affinity uptake system for ACh exists in central ganglia. In these experiments, the connective tissue sheath that surrounds the ganglia and contains some muscle cells was manually trimmed away so the ganglia consisted predominantly of neuronal cell bodies and neuropil, although the connective tissue could not be removed completely (Coggeshall, 1967) . Paired buccal ganglia were incubated in either 50 nM 3H-ACh or 50 nM 'H-Ch in the presence of 100 PM eserine, which fully inhibits the considerable AChE activity found in ganglia . After incubation for 30 min, the ganglion to bath ratio was 13.0 -t 1.8 (*SD, II = 3) for labeled ACh, and 5.7 f 0.9 for labeled choline. Ganglia : bath ratios were calculated as (cpm/mg wet weight ganglion) t (cpm/ ~1 bath volume). The uptake of ACh was very similar to that observed in 15 muscles, while that of choline was about twice that observed in the muscle. Finally, since abdominal ganglia were generally used for previous studies of choline uptake, the uptake of labeled ACh into this ganglion was also measured. In identical experiments to those described above, the ganglion to bath ratio was 10.2 f 1.9 (*SD, n = 3) a value very similar to that observed for the buccal ganglia. In the case of the abdominal ganglion, the nature of the labeled substance present in the ganglion was analyzed by HPLC. Most of the label (74.8 -t l.O%, *SD, n = 3) was found to be ACh even when the 30 min wash period used to remove extracellular label was carried out in the absence of eserine. Thus, central ganglia also contain a high-affinity uptake system for ACh, and this ACh is sequestered away from AChE activity.
Stimulation increases 3H-choline uptake and ACh synthesis but not jH-ACh uptake When I5 muscles were incubated for 30 min in 50 nM 3H-choline, 36 + 7% (*SD, N = 10) of soluble label was found as ACh. The remaining label was divided between choline and an unidentified substance(s). To carry out stimulation experiments, the axons of B 15 and B 16 were stimulated via an extracellular suction electrode on nerve N3. This simplified carrying out the experiments, although other axons such as those of the serotonergic metacerebral cell would also be stimulated . However, control experiments indicated that serotonin does not change either choline or ACh uptake (Phares and Lloyd, 1992) . Nevertheless, intracellular stimulation of the MNs does not markedly simplify the situation as this is known to evoke release of peptide cotransmitters including some that are likely to have presynaptic actions on ACh release Lloyd, 1989, 1990; Cropper et al., 1990a,b) . Paired unstimulated I5 muscles from one animal incubated in 50 nM 3H-choline synthesized very similar amounts oflabeled ACh (right : left ratio, 1.00 + 0.17, *SD, n = 5). Stimulation of N3 increased labeled choline uptake and ACh synthesis markedly. When N3 to one muscle was stimulated, 3H-choline uptake doubled and labeled ACh increased -five-fold. Both increases appeared to be linear up to 40 min (Fig. 8) . Essentially, all (97.4 f 5.0%; SD, n = 5) of the increased uptake of labeled choline was found to be synthesized into ACh (Fig. 9) . There was no significant change in other labeled substances (stim/control, 1.04 f 0.07). When the same experiment was repeated using 50 nM 3H-ACh, stimulation did not change total uptake or the ratio Figure 8 . A, Stimulation of nerve N3 (which contains the axons of the MNs which innervate 15) increased the rate of uptake of 50 nM 'H-Ch, which was linear for at least 40 min. Two muscles from the same animal were incubated in a single bath with 3H Ch. A suction electrode was used to stimulate N3 to one of the muscles at 25 Hz for 4 set with 6 set interburst intervals. B, Stimulation of nerve N3 increased the rate of labeled ACh synthesis from 'H Ch which was linear for at least 40 min. After incubation and washing, muscle extracts were run on HPLC to determine the fate of labeled Ch (see Fig. 9 ).
of labeled ACh found in the muscle (stim/control, 1.04 f 0.3 1 for uptake, 1.04 -t 0.07 for 3H-ACh in muscle, &SD, n = 6). Thus, the high-affinity uptake of choline but not ACh was increased by stimulation. However, it should be noted that even when increased by stimulation, choline uptake was still half the velocity of ACh uptake.
Evidence that the stimulation-dependent increase in choline uptake is localized to MN axonaljbers The finding that all of the stimulation-dependent increase in choline uptake is synthesized into ACh suggests that this uptake occurs into a region with high CAT activity. The most likely identity for this region is the axonal fibers of the MNs. Two Muscles were then washed, extracted, and run on HPLC. Control is the profile from the unstimulated muscle. Stim. is the profile of the stimulated muscle. Stim. -Control is the difference between the two muscles. Note that all the additional labeled Ch taken up by the stimulated muscles was synthesized into ACh.
additional lines of evidence support this hypothesis. First, the stimulation-dependent increase in choline uptake has a very low capacity, as would be expected if the uptake was into a very small portion of 15 neuromuscular preparation. The stimulation-dependent increase in choline uptake is concentration dependent, with the effect essentially disappearing at concentrations of choline at or above 10 I.LM (Fig. lOA) . Subtracting uptake into stimulated muscles from uptake into the paired resting muscles revealed a stimulation-dependent high-affinity/low-capacity uptake system for choline, which saturated at -3 PM and had an apparent K,,, below 1 PM (Fig. 10B) . Second, the stimulation-evoked increase in 'H-choline uptake or synthesis of labeled ACh is not affected by blocking EJPs with the cholinergic antagonist hexamethonium. Paired muscles were both stimulated as described above in the presence of 3H-choline, but one muscle was incubated in sufficient hexamethonium (0.5 mM) to substantially block EJPs and to abolish contractions (Whim and Lloyd, 1990) . There are no differences between the muscle pairs in total uptake (control/hexamethoniurn, 0.97 f 0.14, *SD, N = 4) or in labeled ACh synthesis (control/hexamethonium, 1.11 * 0.17). Thus, the increases in choline uptake and ACh synthesis are independent of cholinergic depolarization of muscle fibers or muscle contractions. Figure 10 . The effects of N3 stimulation on Ch uptake into I5 muscles decreased with increasing concentrations of Ch. Paired muscles from an animal were incubated with labeled Ch in the same dish and N3 to one muscle stimulated via a suction electrode (4 set, 25 Hz bursts with 6 set intervals for 30 min). A, Unlabeled Ch was added to 10 nM 'HCh to produce the indicated concentrations. Incubation periods were 30 min. Values are mean + SD (n = 3). B, Subtracting uptake of Ch into the stimulated muscle from the uptake into the control muscle for each pair of muscles incubated with the same concentrations of Ch yields a saturating curve. Values are mean ? SD (n = 3). Note that the difference in uptake is very small compared to uptake values presented in Figure 5 .
Again, this suggests that the most likely location for the increased uptake was into presynaptic axonal fibers of the MNs.
Comparison of the rates of uptake and hydrolysis of ACh
In the 15 neuromuscular preparation, two mechanisms are present that are capable of reducing extracellular ACh concentrations, uptake, and hydrolysis. Since we had no way of blocking uptake completely, we reasoned that one way of comparing rates of ACh uptake to AChE activity would be to compare the fate of 10 I.LM 'H-ACh incubated with 15 muscle segments in the presence and absence of 100 FM eserine. The assumption is that the eserine would completely block AChE activity but might not effect uptake (see below). It was necessary to keep the ratio of the muscle volume to bath volume low (muscle : bath of 1: 10) in order to be able to measure hydrolysis of labeled ACh in the bath. However, with this low ratio, the concentration of ACh in the bath will be reduced by uptake. Preliminary experiments suggested that ACh hydrolysis was relatively slow and that 20 min was the optimal incubation period to measure hydrolysis without a large reduction in the concentration of ACh in the bath. Even at 20 min, the ACh concentration was reduced to 4.8 f 0.4 PM (&SD, N = 3) in nASW and to 6.1 -t 0.4 PM in nASW plus eserine. In nASW, more ACh was taken up than was hydrolyzed (Fig. 11) . The presence of eserine blocked measurable hydrolysis of ACh (< 1%) but, as predicted, had no significant effect on uptake (Fig. 11) . Thus, even in nASW, the uptake of ACh is more rapid than its hydrolysis by AChE. However, in the animal most of the AChE activity in muscle is likely to be due to activity found in the blood. The half-life of 3H-ACh in blood is 0.38 f 0.07 min (N = 3; blood diluted 1: 10 in nASW, the half-life would be considerably shorter in undiluted blood) and this activity was completely blocked by 100 PM eserine. However, AChE in blood is particulate and it Figure 12 . Stimulation selectively depletes labeled ACh from muscles preloaded by N3 stimulation in 3H-Ch. Paired muscles were both stimulated as described in Figure 8 . Control is the profile of a muscle that was stimulated in labeled Ch then rested (no further stimulation). Stim.
is the profile of a muscle that was stimulated in labeled Ch and then stimulated a second time after the labeled Ch had been removed. Stim.
-Control is the difference between the two profiles. A, Second stimulation (25 Hz, 4 set bursts with 6 set intervals for 60 min) was carried out in nASW with no additions. B, Second stimulation (as above) was carried out in nASW containing 100 PM each of unlabeled Ch, eserine, and hexamethonium. With these additions, muscle contractions were largely blocked and AChE activity was completely inhibited. Note that under both conditions, stimulation predominantly depletes labeled ACh.
is not clear what role it would play in hydrolyzing ACh in the synaptic cleft (see Discussion).
Since eserine effectively blocked AChE activity in this preparation, we wished to determine what effects it would have on MN-evoked contractions. In neuromuscular preparations washed extensively with nASW, B15 was stimulated via intracellular electrodes to fire bursts (1 set, 20 Hz bursts at 50 set intervals) which evoke contractions that are an extremely sensitive measure of neuromuscular depolarization in the 15 muscle . At 100 PM, eserine actually caused a decline in the contraction amplitude (to 65 * 10% of control, &SEM, n = 3) presumably due to some action on some aspect of neuromuscular transmission other than AChE. A lower concentration of eserine (30 PM) did cause a moderate increase in contraction amplitude (to 112 & 3% of control, n = 3). Unfortunately, all types of AChE inhibitors have been found to interact with cholinergic receptors in Aplysiu (Fossier et al., 1983 (Fossier et al., , 1984 (Fossier et al., , 1986 ). Thus, eserine had only moderate effects on evoked contractions, suggesting that AChE activity does not play a large role in inactivating released ACh in the immediate region ofthe postjunctional cholinergic receptors.
ACh is the predominant labeled substance released in a stimulation-dependent marzner When both neuromuscular preparations from an animal were loaded by nerve stimulation in labeled choline, they made much more labeled ACh than resting preparations and the amounts in each muscle were very similar (right : left ratio, 0.95 f 0.03, N = 3). Other labeled substances were also similar. Thus, if both neuromuscular preparations from an animal were loaded under identical conditions, washed, and then N3 to one muscle stim- . In all cases. the increased label collected during stimulation was nearly all ACh and Ch, but the ratio between the two was modified by adding eserine (100 FM) to the nASW, or by adding eserine and hexamethonium (500 PM) to the nASW. Composition of the collected labeled material was determined by HPLC. Values are mean -+ SD (n = 4 preparations).
ulated, released substances should be depleted from the stimulated side. Figure 12 shows examples of experiments done using this paradigm. The results of these experiments indicate that ACh is the major labeled substance depleted in a stimulation-dependent manner. The nature of the labeled substances collected from neuromuscular preparations was also directly measured. 15 preparations were loaded by stimulation of N3 in the presence of labeled choline, then washed for 30 min and mounted in a collection apparatus perfused with nASW. In resting neuromuscular preparations, the collected label was mostly 3H-choline in nASW alone (85.9 f 8.3%, *SD, n = 4 for each), in nASW plus 100 I.LM eserine (88.4 ? 7.8%) and in nASW plus eserine and 500 PM hexamethonium (90.3 * 2.6%). Since eserine had no effect on this composition, the material collected from resting muscles probably represents choline gradually washing from the muscle. Nerve stimulation (25 Hz in 4 set bursts) increased the amount of collected label 3.13 f 1 .OO (? SD, n = 12) fold with a good deal of variability between preparations even under the same conditions. The stimulation-dependent increase in collected label was composed predominantly of choline and ACh, but the relative composition was dependent on the perfusate. In nASW, somewhat more choline than ACh was collected (Fig. 13) . Inhibiting AChE activity with eserine increases the proportion of label collected as ACh, suggesting that in nASW some hydrolysis of released ACh was occurring (Fig. 13) . However, even in the presence of eserine, stimulation increased the recovery of labeled choline. Collected label was nearly all ACh when the EJPs and contractions were also inhibited with hexamethonium (Fig. 13) . This suggests that stimulation caused a small increase in labeled choline efflux from the muscles presumably in response to the EJPs or contractions. Still, even in nASW alone, the stimulationdependent increase in collected label represents predominantly ACh released from terminals, although some of it has been hydrolyzed to choline. Of course, we expect that the labeled ACh and choline collected from neuromuscular preparations will be reduced to some degree by the high-affinity uptake systems.
Collection of labeled ACh and choline during intracellular stimulation of B15 or B16 We were interested in directly determining how stimulationdependent recovery of label is regulated by the stimulation frequency in individual MNs. After 15 neuromuscular preparations were loaded by stimulation of N3 during incubation in 3H-choline, individual B 15 or B 16 somata were impaled with two electrodes to control their electrical activity. In these experiments, only the 15 neuromuscular preparation was bathed in nASW while other muscles and the buccal ganglion were bathed in low-Ca2+/high-Mg*+ ASW. Under these conditions, B16 was often spontaneously active, while B 15 was always silent. In the experiments involving B 15 stimulation, B 16 was first impaled with an electrode and mechanically lesioned. Each MN was fired at a series of frequencies in 4 set bursts with 3 set intervals for 60 sec. Perfusate was collected as described for the nerve stimulation experiments. The label collected during a stimulation period was subtracted from two control collection periods before and after stimulation. Because levels of collected label fell off gradually during the experiments, stimulation at each frequency was bracketed with, and normalized to release during 10 Hz stimulation periods. Similar results were obtained for B 15 and B16 (Fig. 14) . Stimulation-dependent increases in collected label could be monitored at frequencies as low as 7.5 Hz (a total of 270 spikes in a single neuron) and as the frequency was increased the collected label increased markedly. When corrected for total number of spikes, the label collected per spike increased about IO-fold between 7.5 Hz and 25 Hz, the highest frequency used in this study. As discussed above, we expect that the label collected from neuromuscular preparations will be reduced to some degree by the high-affinity uptake systems.
Discussion
The survey of identified buccal MNs indicated that the majority of these neurons use ACh as a fast excitatory transmitter. However, several MNs are not cholinergic and use a fast excitatory transmitter that we believe is an excitatory amino acid and probably glutamate (Fox and Lloyd, 1993) . 'This observation is reminiscent of previous studies. For example, gill muscles of Aplysia were found to be innervated by both cholinergic and noncholinergic MNs (Carew et al., 1974) . In addition, crustacean MNs are primarily glutamatergic (Gerschenfeld, 1973) , but some have been shown to be cholinergic (Marder, 1976) . In the present study, several of the buccal cholinergic MNs were inhibitory or mixed inhibitory/excitatory, but all of the noncholinergic MNs were excitatory. An interesting observation is that in muscle fibers in which the cholinergic MNs produce either an inhibitory or mixed response, the purely excitatory MNs to those fibers were noncholinergic (Church and Lloyd, 1991; Church et al., 1993) . These results fit well with a hypothesis that postsynaptic neurons express the same type(s) of cholinergic receptors at all synapses made onto them by cholinergic neurons (Segal and Koester, 1982) . Thus, it is possible that in muscle fibers that express inhibitory cholinergic receptors, the excitatory transmitter must be something other than ACh.
We have shown that the 15 neuromuscular system expresses separate high-affinity uptake systems for ACh and choline. The high-affinity uptake system for ACh is inhibited much more effectively by high concentrations of ACh or by reducing external Na+ concentrations than the high-affinity uptake system for choline. The velocity of uptake for ACh is about fourfold higher than that for choline in an unstimulated preparation. Even when choline uptake is increased by stimulation of motor axons, ACh uptake rates remain twice those for choline. The evidence suggests that the increase in uptake of labeled choline caused by stimulation occurs predominantly in the cholinergic axonal fibers in muscle. First, all of the increased uptake of choline is synthesized into ACh. Thus, the choline is taken up into a region rich in CAT activity. This is likely to be the cholinergic axonal fibers, since most of the choline taken up into muscle fibers in the absence of stimulation is not metabolized to ACh. Second, this increased choline uptake and ACh synthesis caused by stimulation is unchanged when postsynaptic responses are inhibited by hexamethonium. Again, this makes it likely that the site of the stimulation-dependent changes are the presynaptic axonal fibers. It is perhaps surprising that this should be the case given that these terminals make up such a small proportion of the volume of this neuromuscular preparation. However, it may be that the very low concentrations of choline (150 nM) used in many of these studies ensured that almost all of the uptake is through a high-affinity system that is expressed preferentially in the presynaptic MN fibers (see also . The finding that the rate of the high-affinity uptake of ACh is not changed by stimulation could be because ACh is taken up by muscles cells or glia, or the uptake is into MN fibers and it is simply regulated differently from the high-affinity uptake system for choline. Perhaps the choline uptake system is primarily responsible for maintaining homeostatic levels of ACh because choline is always readily available in substantial concentrations in the blood . Taken together, our results suggest that the additional labeled choline and ACh collected from 15 neuromuscular preparations during stimulation is predominantly due to release of ACh from MN terminals and is therefore a reasonable reflection of this release. Thus, it should prove possible to determine factors that regulate conventional transmitter release in a preparation that has become a model system for the study ofthe release of peptide cotransmitters Lloyd, 1989, 1990; Cropper et al., 1990a; Villim et al., 1991; Phares and Lloyd, 1992) . In this regard, it is interesting to note that ACh release from terminals of B 15 appears to increase smoothly with stimulation frequency. In contrast, there appears to be a discrete frequency threshold for the release of B 15's cotransmitters (the SCPs) below which no release occurs Lloyd, 1989, 1990 ). However, it should also be noted that the uptake of ACh, and to a lesser degree that of choline produced by hydrolysis of ACh, will always ensure that the collected label underrepresents the release of labeled ACh.
Several aspects of the results presented here differ significantly from those obtained previously from studies carried out in the abdominal ganglion. In one study, release experiments were carried out on neurons injected with 3H-choline (Koike et al., 1974) . Although the injected labeled choline was efficiently synthesized into ACh, only labeled choline was recovered from the perfusate after intracellular stimulation suggesting rapid hydrolysis by AChE. This hydrolysis was not prevented by a variety of AChE inhibitors. It is possible that the existence of the highaffinity uptake system for ACh we have described in the abdominal ganglion contributed to the inability to recover labeled ACh. In the present experiments, nearly half of the label collected during stimulation was ACh in the complete absence of inhibitors of AChE or uptake. It is also possible that the different results may also reflect differences in the methods of loading the synapses with labeled ACh. In the study of the abdominal ganglion, labeled choline was injected into the cell body and an interval provided for synthesis of ACh and diffusion or transport to terminals. In our study, labeled choline was taken up during stimulation and the labeled ACh appears to be confined to the MN terminals. Presumably, this latter mode of loading is more physiological. A second major difference with the results of a previous study is the finding in the abdominal ganglion that nerve stimulation did not increase either choline uptake or ACh synthesis (Eisenstadi et al., 1975) . This was interpreted as being a reflection of the large pools of ACh found in Aplysia neurons. We found that stimulation produced large increases in both choline uptake and ACh synthesis in the 15 neuromuscular preparation that were qualitatively similar to those observed for vertebrate neuromuscular preparations (Potter, 1970; Vaca and Pilar, 1979) . It is possible that stimulation of peripheral nerves to the 15 muscle is much more effective at activating cholinergic terminals than stimulation of nerve roots leading back into the abdominal ganglion. An alternative explanation is that cholinergic metabolism in central and peripheral synapses in Aplysia differ significantly.
The quantitative relationship between hydrolysis of ACh by endogenous AChE and high-affinity uptake of ACh appears to differ significantly between the 15 neuromuscular system and vertebrate skeletal neuromuscular preparations. For example, in rat diaphragm, there is no measurable uptake of ACh in the absence of an AChE inhibitor, and even in the presence of an inhibitor, the rate of ACh uptake was half that observed for choline under identical conditions (using 10 PM ACh or choline; Potter, 1970) . In the Aplysia 15 system, there is measurable AChE activity, but the presence of an AChE inhibitor has little effect on ACh uptake. In addition, at concentrations of 10 PM, the rate of ACh uptake is about fourfold that of choline. It is possible that under normal physiological conditions, the AChE activity in blood is responsible for the rapid hydrolysis of released ACh. However, AChE activity in Aplysia blood is associated with particles that are retained by filters with a pore size of 200 nm (Giller and Schwartz, 197 1 b; Bevelaqua et al., 1975) . Since the synaptic cleft in 15 muscle is about 20 nm across (Kupfermann et al., 1982; Cropper et al., 1987a) , it is not clear what role the blood AChE would play in the rapid hydrolysis of released ACh. It appears likely that it primarily hydrolyzes ACh, which has already diffused from the synapse. Neural elements in the 15 muscle do stain with a histochemical procedure for cholinesterase, but staining was not confined to varicosities and even large nonvaricose axons stained. This suggests that the small amount of AChE activity endogenous to this neuromuscular preparation may not even be concentrated at synapses . Thus, at these cholinergic neuromuscular synapses, efficient uptake of the unhydrolyzed transmitter may play a role in reducing the concentration of ACh in the synaptic cleft, as has been suggested for the biogenic amines and amino acid transmitters (Brims et al., 1993; Mennerick and Zorumski, 1994) .
Recordings from behaving animals indicate that both B15 and B16 can fire in sustained bursts with a duration of a few seconds and brief interburst intervals similar to the pattern used in this study (Cropper et al., 1990~) . Our direct measurements of collected label suggest that the two motor neurons show similar frequency-dependent increases in release per spike (-lofold range for the frequencies tested). Cohen et al. (1978) concluded that the EJPs from B 15 showed much greater facilitation than those from B 16 by comparing the size of EJPs generated by two action potentials fired intracellularly with varying intervals. Differences in stimulation parameters may underlie this apparent contradiction, since our stimulation paradigm used a train of long duration bursts.
In conclusion, we have shown that ACh is a major conventional excitatory transmitter of buccal neuromuscular synapses. We also found that the 15 neuromuscular system is amenable to the investigation of the release of a conventional transmitter from the terminals of individual identified MNs. We now intend to compare the regulation of peptide cotransmitters and ACh release from the terminals of the same neurons. We have also raised the possibility that the uptake of ACh may play a role in transmitter inactivation at these synapses similar to what has been observed elsewhere for noncholinergic transmitters.
